Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial
| Image |  |
|---|---|
| Description | scientific article published on 03 April 2020 |
| Author/s |
author: Roy S. Herbst Kurt A Schalper |
| Publication date | April 3, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |